Active substances
Chlorphenamine + Pseudoephedrine
- SFDA 2
- US FDA 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ALLERGETIN SYRUP | 2,30 mg,mg | Syrup · Oral use | 1 Bottle | SAR 2.55 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| FLUMED | 0.4, 6 mg/ml | Syrup · Oral use | 1 Bottle | SAR 2.75 | NCE · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE COUGH; BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CHLOR-TRIMETON | 8MG;120MG | tablet, extended release · oral | BAYER HEALTHCARE LLC | Discontinued | 31 Mar 1981 |
| PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE | 12MG;120MG | capsule, extended release · oral | GRAHAM DM | Discontinued | 18 Mar 1985 |
| PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE | 8MG;120MG | capsule, extended release · oral | GRAHAM DM | Discontinued | 20 Mar 1985 |
| ISOCLOR | 8MG;120MG | capsule, extended release · oral | FISONS | Discontinued | 6 Mar 1986 |
| PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE | 8MG;120MG | capsule, extended release · oral | CENT PHARMS | Discontinued | 2 Aug 1988 |
| PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE | 12MG;120MG | capsule, extended release · oral | KV PHARM | Discontinued | |
| CODIMAL-L.A. 12 | 12MG;120MG | capsule, extended release · oral | SCHWARZ PHARMA | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.